Filing Details
Glucotrack, Inc. (NASDAQ:GCTK) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
8k filedNASDAQ:GCTK
Glucotrack, Inc. (GCTK) Reports Material Event to SEC
Filing Details Glucotrack, Inc. (NASDAQ:GCTK) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market Context…
Market Context
Glucotrack, Inc.'s stock currently trades at $0.53 with a market capitalization of $3.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Glucotrack, Inc.'s stock.
All SEC filings for Glucotrack, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GCTK Stock Page
Frequently Asked Questions
Where can I read GCTK's SEC filings?
Browse all filings on our GCTK SEC filings page.
What types of SEC filings does Glucotrack, Inc. file?
Public companies like Glucotrack, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.